Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × tislelizumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 12 Colorectal Neoplasms 9 Advanced Solid Tumor 6 Neoplasm Metastasis 5 Carcinoma, Hepatocellular 4 Lung Neoplasms 3 Stomach Neoplasms 2 Rectal Neoplasms 2 Nasopharyngeal Carcinoma 2 Lymphoma, Follicular 2 Head and Neck Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Advanced Solid Tumour 2 mCRPC 1 Squamous Cell Carcinoma of Head and Neck 1 Squamous Cell Carcinoma of External Auditory Canal 1 Solid Tumor 1 Simpson-Golabi-Behmel syndrome 1 Pseudomyxoma Peritonei 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Non Squamous Non-small Cell Lung Cancer 1 Neoplasm, Residual 1 Nasopharyngeal Neoplasms 1 NSCLC 1 Muscle Invasive Bladder Cancer (MIBC) 1 Metastatic Solid Tumors 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cisplatin 8 Pemetrexed 7 Carboplatin 4 Platinum 3 Nivolumab 3 Ipilimumab 3 1,2-diaminocyclohexaneplatinum II citrate 3 tremelimumab 2 pembrolizumab 2 durvalumab 2 Cyclophosphamide 2 methoxyamine 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 cediranib 1 bintrafusp alfa protein, human 1 atezolizumab 1 aldesleukin 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 Pharmaceutical Preparations 1 Interleukin-2 1 In Situ Hybridization, Fluorescence 1 Imprint II 1 Immunoglobulin G 1 Gemcitabine 1 Etoposide 1 Disulfides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡